Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q14032: Variant p.Gly386Arg

Bile acid-CoA:amino acid N-acyltransferase
Gene: BAAT
Feedback?
Variant information Variant position: help 386 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help US The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance

Residue change: help From Glycine (G) to Arginine (R) at position 386 (G386R, p.Gly386Arg). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from glycine (G) to large size and basic (R) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -2 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page

Variant description: help In BACD1; uncertain significance; contrary to wild-type, undetectable expression in hepatocytes. Any additional useful information about the variant.


Sequence information Variant position: help 386 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 418 The length of the canonical sequence.
Location on the sequence: help PPYSPLCCASTTHDLRLHWG G EVIPHAAAQEHAWKEIQRFL The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences.
Human                         PPYSPLCCASTTHDL--RLHWGGEVIPHAAAQEHAWKEIQRFL

Mouse                         PPYTPLCQASRMPILIPSLSWGGEVIPHAAAQEHSWKEIQK

Rat                           PPYSPLCSASRMPFVIPSINWGGEVIPHAAAQEHSWKEIQK

Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 418 Bile acid-CoA:amino acid N-acyltransferase
Mutagenesis 372 – 372 C -> A. Retains N-acyltransferase activity.



Literature citations
Genetic defects in bile acid conjugation cause fat-soluble vitamin deficiency.
Setchell K.D.; Heubi J.E.; Shah S.; Lavine J.E.; Suskind D.; Al-Edreesi M.; Potter C.; Russell D.W.; O'Connell N.C.; Wolfe B.; Jha P.; Zhang W.; Bove K.E.; Knisely A.S.; Hofmann A.F.; Rosenthal P.; Bull L.N.;
Gastroenterology 144:945-955(2013)
Cited for: INVOLVEMENT IN BACD1; VARIANTS BACD1 20-ARG--LEU-418 DEL; VAL-69; THR-84 AND ARG-386; CHARACTERIZATION OF VARIANTS BACD1 20-ARG--LEU-418 DEL; VAL-69 AND ARG-386; SUBCELLULAR LOCATION; TISSUE SPECIFICITY;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.